Novel Oral Anticoagulants Following Percutaneous Coronary Intervention.

Circulation. Cardiovascular Interventions
Bryan Q AbadieMatthew A Cavender

Abstract

Antiplatelet and anticoagulant medications are the cornerstone of therapy for patients with acute coronary syndrome and have also been shown to reduce recurrent cardiovascular events in patients with stable coronary disease. Whereas antiplatelet medications have been the preferred therapy for long-term secondary prevention, the development of novel oral anticoagulants has renewed interest in the use of anticoagulation to prevent atherosclerotic events. In patients with atrial fibrillation or other indications for anticoagulation, recent clinical trials have shown the benefit of double therapy with full-dose novel oral anticoagulants and P2Y12 inhibitors compared with regimens with vitamin K antagonists. In patients without an indication for anticoagulation, the use of low doses of the factor Xa inhibitor, rivaroxaban, has shown benefit. Clinicians have many pharmacological options when treating patients following percutaneous coronary intervention. This review discusses the evidence for the use of novel oral anticoagulants, with an emphasis on patient selection, choice of therapy, and appropriate dosing of anticoagulant and antiplatelet agents, in secondary prevention strategies for atherosclerosis following coronary revascular...Continue Reading

References

Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Jul 16, 2010·Journal of Thrombosis and Haemostasis : JTH·F RodeghieroUNKNOWN ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group
Jul 26, 2011·The New England Journal of Medicine·John H AlexanderUNKNOWN APPRAISE-2 Investigators
Nov 15, 2011·The New England Journal of Medicine·Jessica L MegaUNKNOWN ATLAS ACS 2–TIMI 51 Investigators
Oct 17, 2014·European Heart Journal. Acute Cardiovascular Care·Matthew A CavenderJessica L Mega
Nov 18, 2014·The New England Journal of Medicine·Laura MauriUNKNOWN DAPT Study Investigators
Mar 17, 2015·The New England Journal of Medicine·Marc P BonacaUNKNOWN PEGASUS-TIMI 54 Steering Committee and Investigators
Mar 30, 2016·JAMA : the Journal of the American Medical Association·Robert W YehUNKNOWN DAPT Study Investigators
Dec 14, 2016·The New England Journal of Medicine·C Michael GibsonKeith A Fox
Aug 19, 2017·Advances in Medical Sciences·Ewelina MichniewiczJolanta Malyszko
Aug 29, 2017·The New England Journal of Medicine·John W EikelboomUNKNOWN COMPASS Investigators
Aug 29, 2017·The New England Journal of Medicine·Christopher P CannonUNKNOWN RE-DUAL PCI Steering Committee and Investigators
Jul 6, 2018·Nature Reviews. Cardiology·Davide CapodannoDominick J Angiolillo
Jan 23, 2019·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Franz-Josef NeumannMichael O Zembala
Mar 19, 2019·The New England Journal of Medicine·Renato D LopesUNKNOWN AUGUSTUS Investigators
Jul 6, 2019·Journal of the American College of Cardiology·Davide CapodannoDominick J Angiolillo
Jul 20, 2019·Therapeutic Advances in Hematology·Sung Won ChoDominick J Angiolillo
Sep 3, 2019·The New England Journal of Medicine·Satoshi YasudaUNKNOWN AFIRE Investigators
Sep 11, 2019·European Heart Journal·Juhani KnuutiUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Citations

Mar 13, 2021·The American Journal of Cardiology·Christopher P Cannon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Related Papers

Postępy w kardiologii interwencyjnej = Advances in interventional cardiology
Iwona Gorczyca-Michta, Beata Wożakowska-Kapłon
Cardiovascular Drugs and Therapy
Newton B WigginsJohn H Alexander
Current Problems in Cardiology
Rahul SakhujaDeepak L Bhatt
© 2021 Meta ULC. All rights reserved